Insider Buy/Sell Details for the Healthcare Sector — Last 30 Days
Ratio0.2:1
Daily Buy & Sell Volume
Transactions (1733)
Krystal Biotech, Inc. (KRYS)
Krishnan Suma — Director
Shares
2,801
Price
$309.95
Total Value
$868.16K
Shares Held After
1,380,434
% of Holdings
0.2%
Krystal Biotech, Inc. (KRYS)
Krishnan Suma — Director
Shares
3,803
Price
$308.89
Total Value
$1.17M
Shares Held After
1,383,235
% of Holdings
0.3%
Krystal Biotech, Inc. (KRYS)
Krishnan Suma — Director
Shares
12,729
Price
$307.81
Total Value
$3.92M
Shares Held After
1,387,038
% of Holdings
0.9%
Krystal Biotech, Inc. (KRYS)
Krishnan Suma — Director
Shares
1,348
Price
$307.09
Total Value
$413.96K
Shares Held After
1,399,767
% of Holdings
0.1%
Krystal Biotech, Inc. (KRYS)
Krishnan Suma — Director
Shares
480
Price
$305.87
Total Value
$146.82K
Shares Held After
1,401,115
% of Holdings
0.0%
Krystal Biotech, Inc. (KRYS)
Krishnan Suma — Director
Shares
400
Price
$304.89
Total Value
$121.96K
Shares Held After
1,401,595
% of Holdings
0.0%
Krystal Biotech, Inc. (KRYS)
Krishnan Suma — Director
Shares
247
Price
$303.17
Total Value
$74.88K
Shares Held After
1,401,995
% of Holdings
0.0%
Krystal Biotech, Inc. (KRYS)
Krishnan Suma — Director
Shares
593
Price
$302.25
Total Value
$179.23K
Shares Held After
1,402,242
% of Holdings
0.0%
Krystal Biotech, Inc. (KRYS)
Krishnan Suma — Director
Shares
320
Price
$300.75
Total Value
$96.24K
Shares Held After
1,402,835
% of Holdings
0.0%
908 Devices Inc. (MASS)
Brown Christopher D. — Director
Shares
100
Price
$9.00
Total Value
$900.00
Shares Held After
875,459
% of Holdings
0.0%
Pacira BioSciences, Inc. (PCRX)
WILLIAMS KRISTEN — Chief Administrative Officer
Shares
10,259
Price
$22.27
Total Value
$228.47K
Shares Held After
167,062
% of Holdings
5.8%
NovoCure Ltd (NVCR)
Leonard Frank X — Chief Executive Officer
Shares
34,273
Price
$17.93
Total Value
$614.63K
Shares Held After
459,520
% of Holdings
6.9%
MiNK Therapeutics, Inc. (INKT)
Ryan Barbara — Director
Shares
1,000
Price
$12.80
Total Value
$12.80K
Shares Held After
21,969
% of Holdings
4.4%
MiNK Therapeutics, Inc. (INKT)
Ryan Barbara — Director
Shares
500
Price
$12.68
Total Value
$6.34K
Shares Held After
22,969
% of Holdings
2.1%
CG Oncology, Inc. (CGON)
POST LEONARD E — Director
Shares
1,000
Price
$54.50
Total Value
$54.50K
Shares Held After
0
% of Holdings
100.0%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
120
Price
$550.48
Total Value
$66.06K
Shares Held After
18,876
% of Holdings
0.6%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
1,298
Price
$549.06
Total Value
$712.68K
Shares Held After
18,996
% of Holdings
6.4%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
2,749
Price
$548.04
Total Value
$1.51M
Shares Held After
20,294
% of Holdings
11.9%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
1,033
Price
$547.00
Total Value
$565.05K
Shares Held After
23,043
% of Holdings
4.3%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
1,129
Price
$545.89
Total Value
$616.31K
Shares Held After
24,076
% of Holdings
4.5%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
1,545
Price
$544.94
Total Value
$841.94K
Shares Held After
25,205
% of Holdings
5.8%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
1,086
Price
$544.11
Total Value
$590.91K
Shares Held After
26,750
% of Holdings
3.9%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
440
Price
$542.78
Total Value
$238.82K
Shares Held After
27,836
% of Holdings
1.6%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
480
Price
$541.14
Total Value
$259.75K
Shares Held After
28,276
% of Holdings
1.7%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
120
Price
$539.64
Total Value
$64.76K
Shares Held After
28,756
% of Holdings
0.4%
Xeris Biopharma Holdings, Inc. (XERS)
HALKUFF DAWN — Director
Shares
20,000
Price
$6.09
Total Value
$121.89K
Shares Held After
95,000
% of Holdings
17.4%
Kodiak Sciences Inc. (KOD)
BORGESON JOHN A. — Chief Financial Officer
Shares
4,104
Price
$34.67
Total Value
$142.29K
Shares Held After
211,930
% of Holdings
1.9%
Kodiak Sciences Inc. (KOD)
BORGESON JOHN A. — Chief Financial Officer
Shares
25,896
Price
$34.01
Total Value
$880.72K
Shares Held After
216,034
% of Holdings
10.7%
Xeris Biopharma Holdings, Inc. (XERS)
JOHNSON JOHN — Director
Shares
15,000
Price
$6.09
Total Value
$91.42K
Shares Held After
683,083
% of Holdings
2.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
560
Price
$550.46
Total Value
$308.26K
Shares Held After
40,513
% of Holdings
1.4%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
780
Price
$549.24
Total Value
$428.41K
Shares Held After
41,073
% of Holdings
1.9%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,676
Price
$548.26
Total Value
$918.89K
Shares Held After
41,853
% of Holdings
3.9%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,525
Price
$547.53
Total Value
$834.98K
Shares Held After
43,529
% of Holdings
3.4%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,202
Price
$546.14
Total Value
$656.46K
Shares Held After
45,054
% of Holdings
2.6%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,186
Price
$545.18
Total Value
$646.59K
Shares Held After
46,256
% of Holdings
2.5%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,470
Price
$544.24
Total Value
$800.04K
Shares Held After
47,442
% of Holdings
3.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
396
Price
$543.11
Total Value
$215.07K
Shares Held After
48,912
% of Holdings
0.8%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
112
Price
$542.50
Total Value
$60.76K
Shares Held After
49,308
% of Holdings
0.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
473
Price
$541.08
Total Value
$255.93K
Shares Held After
49,420
% of Holdings
0.9%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
120
Price
$539.51
Total Value
$64.74K
Shares Held After
49,893
% of Holdings
0.2%
Beta Bionics, Inc. (BBNX)
Hopman Mark — Chief Commercial Officer
Shares
275
Price
$12.31
Total Value
$3.39K
Shares Held After
130,612
% of Holdings
0.2%
Beta Bionics, Inc. (BBNX)
Jones Christy — Director
Shares
2,811
Price
$14.00
Total Value
$39.35K
Shares Held After
27,400
% of Holdings
9.3%
Xeris Biopharma Holdings, Inc. (XERS)
BORMANN-KENNEDY BARBARA-JEAN ANNE — Director
Shares
16,000
Price
$6.09
Total Value
$97.51K
Shares Held After
126,500
% of Holdings
11.2%
Progyny, Inc. (PGNY)
Livingston Mark S. — CHIEF FINANCIAL OFFICER
Shares
599
Price
$25.50
Total Value
$15.27K
Shares Held After
74,688
% of Holdings
0.8%
Progyny, Inc. (PGNY)
Livingston Mark S. — CHIEF FINANCIAL OFFICER
Shares
1,918
Price
$25.50
Total Value
$48.91K
Shares Held After
75,287
% of Holdings
2.5%
Equillium, Inc. (EQ)
Connelly Stephen — President and CSO
Shares
200,000
Price
$3.16
Total Value
$632.76K
Shares Held After
793,000
% of Holdings
20.1%
Progyny, Inc. (PGNY)
Swartz Allison — EVP, GC
Shares
599
Price
$25.08
Total Value
$15.02K
Shares Held After
82,378
% of Holdings
0.7%
ImmunityBio, Inc. (IBRX)
Simon Barry J. — Director
Shares
23,033
Price
$7.18
Total Value
$165.31K
Shares Held After
2,827,788
% of Holdings
0.8%
Cadrenal Therapeutics, Inc. (CVKD)
Pham Quang X — Director
Shares
3,898
Price
$4.41
Total Value
$17.19K
Shares Held After
175,288
% of Holdings
2.2%
PROTHENA CORP PUBLIC LTD CO (PRTA)
SCULLY WILLIAM P — 10% Owner
Shares
50,000
Price
$9.31
Total Value
$465.29K
Shares Held After
936,000
% of Holdings
5.3%
Showing 51–100 of 1733 transactions (page 2 of 35)